Evidence map›Paper›PMID 26810130›Full record

ArticleJournal of substance abuse treatment2016

Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.

Jemima A Frimpong, Thomas D'Aunno, Stéphane Helleringer, Lisa R Metsch

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A mixed methods study of HIV-related services in buprenorphine treatment.Substance abuse treatment, prevention, and policy · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jemima A FrimpongDepartment of Health Policy and Management, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA. Electronic address: jf2584@cumc.columbia.edu.
Thomas D'AunnoRobert F. Wagner Graduate School of Public Service, New York University, 295 Lafayette Street, New York, NY, 10012, USA. Electronic address: tdaunno@nyu.edu.
Stéphane HelleringerDepartment of Population, Family and Reproductive Health, Bloomberg School of Public Health, Johns Hopkins University, 615N. Wolfe Street, Baltimore, MD, 21205, USA. Electronic address: sheller7@jhu.edu.
Lisa R MetschDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA. Electronic address: lm2892@cumc.columbia.edu.
Columbia University · USJohns Hopkins University · USWagner College · US

Funding

The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI MILTON L WAINBERG · 2003 to 2026
$48.2M
Mentoring Emerging Scientists for Careers in Substance Use ResearchR25DA035163 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carmen L Masson, Gideon St.Helen · 2014 to 2026
$4.6M
Testing a Comprehensive Model of the Diffusion of Evidence-Based PracticesR01DA030459 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI D'AUNNO, THOMAS · 2011 to 2012
$926k
A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test ResultsR34DA038530 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI D'AUNNO, THOMAS, FRIMPONG, JEMIMA A. · 2015 to 2016
$698k
NIDA NIH HHS R01 DA030459NIDA NIH HHS R01DA030459NIDA NIH HHS R25 DA035163NIDA NIH HHS R25DA035163NIDA NIH HHS R34 DA038530NIDA NIH HHS R34DA038530-01NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

introductionRapid HIV testing (RHT) greatly increases the proportion of clients who learn their test results. However, existing studies have not examined the adoption and implementation of RHT in programs treating persons with substance use disorders, one of the population groups at higher risk for HIV infection.

methodsWe examined 196 opioid treatment programs (OTPs) using data from the 2011 National Drug Abuse Treatment System Survey (NDATSS). We used logistic regressions to identify client and organizational characteristics of OTPs associated with availability of on-site RHT. We then used zero-inflated negative binomial regressions to measure the association between the availability of RHT on-site and the number of clients tested for HIV.

resultsOnly 31.6% of OTPs offered on-site rapid HIV testing to their clients. Rapid HIV testing was more commonly available on-site in larger, publicly owned and better-staffed OTPs. On the other hand, on-site rapid HIV testing was less common in OTPs that prescribed only buprenorphine as a method of opioid dependence treatment. The availability of rapid HIV testing on-site reduced the likelihood that an OTP did not test any of its clients during the prior year. But on-site availability rapid HIV testing was not otherwise associated with an increased number of clients tested for HIV at an OTP.

conclusionsNew strategies are needed to a) promote the adoption of rapid HIV testing on-site in substance use disorder treatment programs and b) encourage substance use disorder treatment providers to offer rapid HIV testing to their clients when it is available.

Indexed as

Opioid-Related DisordersAnalgesics, OpioidBuprenorphineHealth Services AccessibilityHIV InfectionsHumansMass ScreeningSubstance Abuse Treatment CentersUnited StatesAnalgesics, OpioidBuprenorphineAdoptionHIV testingImplementationRapid HIV testingSubstance use disorder treatment programsUse of rapid HIV testing

Identifiers

PMID26810130
PMCPMC4775419
OpenAlexW2202669716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.